“…Sclerotherapy with intralesional injection of sclerosants, including ethanol, morrhuate sodium, sodium tetradecyl sulfate, OK-432 (Picibanil), doxycycline, tetracyclines, bleomycin, or pingyangmycin, is a minimally invasive and effective treatment for orbital venous malformations. 16 , 17 , 20 Nonetheless, a direct puncture with contrast injection under fluoroscopic imaging guidance is typically required to confirm both the needle location within the lesion and the flow characteristics. 1 Furthermore, all sclerosing agents cause direct endothelial injury with resultant thrombosis and fibrotic obliteration of the vascular lumen, with the exception of OK-432, which induces inflammation via cytokine release to achieve the same objective.…”